|
Volumn 20, Issue 10, 2011, Pages 805-809
|
Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice
|
Author keywords
Allergy; Eczema; Escherichia coli Nissle 1917; Probiotics; Regulatory T cells
|
Indexed keywords
ALLERGEN;
CYTOKINE;
GAMMA INTERFERON;
IMMUNOGLOBULIN A;
INTERLEUKIN 10;
MESSENGER RNA;
MUTAFLOR;
PROBIOTIC AGENT;
TRANSCRIPTION FACTOR FOXP3;
TRANSFORMING GROWTH FACTOR BETA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DERMATITIS;
DISEASE SEVERITY;
DOSE RESPONSE;
ECZEMA;
ESCHERICHIA COLI;
FEMALE;
IMMUNE RESPONSE;
IMMUNOCOMPETENT CELL;
IMMUNOHISTOCHEMISTRY;
IMMUNOMODULATION;
MOUSE;
NONHUMAN;
SKIN INFLAMMATION;
SKINFOLD THICKNESS;
SPLEEN CELL;
T LYMPHOCYTE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ALLERGENS;
ANIMALS;
CYTOKINES;
DERMATITIS, ALLERGIC CONTACT;
DISEASE MODELS, ANIMAL;
ESCHERICHIA COLI;
FEMALE;
FORKHEAD TRANSCRIPTION FACTORS;
GENE EXPRESSION;
IMMUNOGLOBULIN A;
MICE;
MICE, INBRED BALB C;
OVALBUMIN;
PROBIOTICS;
RNA, MESSENGER;
T-LYMPHOCYTES, REGULATORY;
|
EID: 80052966421
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/j.1600-0625.2011.01326.x Document Type: Article |
Times cited : (37)
|
References (37)
|